These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12046683)

  • 1. Recent advances in multiple myeloma immunotherapy.
    Ruffini PA; Biragyn A; Kwak LW
    Biomed Pharmacother; 2002 May; 56(3):129-32. PubMed ID: 12046683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in multiple myeloma: current strategies and future prospects.
    Yi Q
    Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
    Ruffini PA; Di Nicola M; Carlo-Stella C; Siena S; Gianni AM
    Curr Gene Ther; 2005 Oct; 5(5):511-21. PubMed ID: 16250891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
    Rhee Fv
    Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiotypic vaccination as therapy for multiple myeloma.
    Kwak LW; Thielemans K; Massaia M
    Semin Hematol; 1999 Jan; 36(1 Suppl 3):34-7. PubMed ID: 9989488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of idiotype vaccines in the treatment of human B-cell malignancies.
    Bendandi M
    Expert Rev Vaccines; 2004 Apr; 3(2):163-70. PubMed ID: 15056042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel immunotherapies.
    Yi Q
    Cancer J; 2009; 15(6):502-10. PubMed ID: 20010170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
    Moshitzky S; Kukulansky T; Haimovich J; Hollander N
    Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of multiple myeloma.
    Ruffini PA; Kwak LW
    Semin Hematol; 2001 Jul; 38(3):260-7. PubMed ID: 11486314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiotype immunity (natural and vaccine-induced) in early stage multiple myeloma.
    Osterborg A; Henriksson L; Mellstedt H
    Acta Oncol; 2000; 39(7):797-800. PubMed ID: 11145435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
    Röllig C; Schmidt C; Bornhäuser M; Ehninger G; Schmitz M; Auffermann-Gretzinger S
    J Immunother; 2011 Jan; 34(1):100-6. PubMed ID: 21150718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic DNA vaccines for B-cell lymphoma therapy.
    Benvenuti F; Cesco-Gaspere M; Burrone OR
    Front Biosci; 2002 Jan; 7():d228-34. PubMed ID: 11779689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects.
    Titzer S; Christensen O; Manzke O; Tesch H; Wolf J; Emmerich B; Carsten C; Diehl V; Bohlen H
    Br J Haematol; 2000 Mar; 108(4):805-16. PubMed ID: 10792287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotypic vaccination in B-cell malignancies.
    Bianchi A; Massaia M
    Mol Med Today; 1997 Oct; 3(10):435-41. PubMed ID: 9358470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational development of vaccination strategies in follicular NHL.
    Sakamaki I; Qin H; Kwak LW
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):295-304. PubMed ID: 21658625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell immunotherapy for cancer: application to low-grade lymphoma and multiple myeloma.
    Hart DN; Hill GR
    Immunol Cell Biol; 1999 Oct; 77(5):451-9. PubMed ID: 10540212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current vaccination strategies for the treatment of B-cell lymphoma and multiple myeloma.
    Hollander N
    Crit Rev Immunol; 2009; 29(5):399-418. PubMed ID: 20001888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic idiotype vaccines in B lymphoproliferative diseases.
    Coscia M; Kwak LW
    Expert Opin Biol Ther; 2004 Jun; 4(6):959-63. PubMed ID: 15174977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma.
    Lim SH; Bailey-Wood R
    Int J Cancer; 1999 Oct; 83(2):215-22. PubMed ID: 10471530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.